E&G Advisors’s Sanofi SNY Stock Holding History

E&G Advisors’s Portfolio SNY Stock Details SNY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$308K	Hold	6,398	–	–	0.07%	177
2025 Q4	$310K	Hold	6,398	–	–	0.07%	168
2025 Q3	$302K	Buy	6,398 +21	+0.3%	+$1.01K	0.07%	176
2025 Q2	$308K	Hold	6,377	–	–	0.08%	164
2025 Q1	$354K	Hold	6,377	–	–	0.1%	145
2024 Q4	$308K	Hold	6,377	–	–	0.08%	161
2024 Q3	$368K	Sell	6,377 -300	-4%	-$16.2K	0.1%	147
2024 Q2	$324K	Hold	6,677	–	–	0.1%	157
2024 Q1	$325K	Buy	6,677 +70	+1%	+$3.42K	0.1%	145
2023 Q4	$329K	Sell	6,607 -143	-2%	-$6.99K	0.12%	143
2023 Q3	$362K	Hold	6,750	–	–	0.13%	135
2023 Q2	$364K	Hold	6,750	–	–	0.13%	142
2023 Q1	$367K	Buy	6,750 +100	+2%	+$4.86K	0.14%	136
2022 Q4	$322K	Sell	6,650 -1,100	-14%	-$48.3K	0.12%	152
2022 Q3	$295K	Sell	7,750 -1,500	-16%	-$66.8K	0.11%	154
2022 Q2	$463K	Hold	9,250	–	–	0.16%	126
2022 Q1	$475K	Hold	9,250	–	–	0.13%	135
2021 Q4	$463K	Hold	9,250	–	–	0.12%	141
2021 Q3	$446K	Buy	+9,250	New	+$470K	0.12%	138
2021 Q2	–	Sell	-9,575	Closed	-$500K	–	132
2021 Q1	$474K	Sell	9,575 -200	-2%	-$9.61K	0.14%	130
2020 Q4	$475K	Hold	9,775	–	–	0.15%	122
2020 Q3	$490K	Sell	9,775 -4,900	-33%	-$252K	0.17%	103
2020 Q2	$749K	Hold	14,675	–	–	0.29%	70
2020 Q1	$642K	Sell	14,675 -2,100	-13%	-$100K	0.32%	66
2019 Q4	$842K	Sell	16,775 -250	-1%	-$11.7K	0.31%	78
2019 Q3	$789K	Hold	17,025	–	–	0.32%	81
2019 Q2	$737K	Sell	17,025 -400	-2%	-$17K	0.31%	81
2019 Q1	$772K	Sell	17,425 -1,200	-6%	-$51.4K	0.34%	81
2018 Q4	$809K	Sell	18,625 -1,300	-7%	-$57.3K	0.37%	78
2018 Q3	$890K	Sell	19,925 -3,400	-15%	-$145K	0.34%	75
2018 Q2	$933K	Sell	23,325 -150	-0.6%	-$5.91K	0.39%	62
2018 Q1	$941K	Sell	23,475 -150	-0.6%	-$6.24K	0.4%	57
2017 Q4	$1.02M	Buy	23,625 +1,400	+6%	+$64.6K	0.43%	53
2017 Q3	$1.11M	Sell	22,225 -1,300	-6%	-$62.9K	0.5%	45
2017 Q2	$1.13M	Buy	23,525 +400	+2%	+$19.1K	0.54%	42
2017 Q1	$1.05M	Buy	23,125 +2,075	+10%	+$88K	0.54%	43
2016 Q4	$851K	Sell	21,050 -2,300	-10%	-$90.6K	0.5%	47
2016 Q3	$892K	Sell	23,350 -300	-1%	-$12K	0.52%	47
2016 Q2	$990K	Sell	23,650 -125	-0.5%	-$5.13K	0.6%	40
2016 Q1	$955K	Sell	23,775 -2,450	-9%	-$98.4K	0.62%	39
2015 Q4	$1.12M	Sell	26,225 -500	-2%	-$23K	0.67%	40
2015 Q3	$1.27M	Hold	26,725	–	–	0.81%	34
2015 Q2	$1.32M	Hold	26,725	–	–	0.77%	38
2015 Q1	$1.32M	Sell	26,725 -200	-0.7%	-$9.56K	0.78%	34
2014 Q4	$1.23M	Sell	26,925 -700	-3%	-$34K	0.8%	38
2014 Q3	$1.56M	Buy	27,625 +1,100	+4%	+$59.1K	1%	31
2014 Q2	$1.41M	Buy	26,525 +1,700	+7%	+$90.2K	0.91%	36
2014 Q1	$1.3M	Buy	24,825 +400	+2%	+$20.2K	1.02%	31
2013 Q4	$1.31M	Buy	+24,425	New	+$1.26M	1.23%	26

Other funds holding SNY

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

MIP

Mondrian Investment Partners London, United Kingdom $6.69B AUM

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

E&G Advisors's SNY Position: Q1 2026 in Review

E&G Advisors held its Sanofi (SNY) position steady in Q1 2026 at 6,398 shares worth $308K. The position accounts for 0.07% of the portfolio, ranked #177.

E&G Advisors first reported a position in SNY in Q4 2013 and has held it in 49 quarters since. The position peaked at $1.56M in Q3 2014. 737 funds tracked by Wall St. Rank hold SNY as of Q1 2026.

E&G Advisors held 6,398 shares of Sanofi worth $308K as of Q1 2026.
E&G Advisors left its Sanofi share count unchanged in Q1 2026.
Sanofi made up 0.07% of E&G Advisors's portfolio in Q1 2026, its #177 holding.
E&G Advisors first reported a position in Sanofi in Q4 2013 and has held it in 49 quarters since.
E&G Advisors's Sanofi position peaked at $1.56M in Q3 2014.
737 funds tracked by Wall St. Rank held Sanofi as of Q1 2026.

Based on E&G Advisors's 13F filing for Q1 2026, filed 21 Apr 2026.